← FDA DRUG APPROVALS

FDA ANDA · ANDA076828

HALOPERIDOL

Sponsor: BAXTER HLTHCARE CORP

APPLICATION
ANDA076828
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-25
LATEST ACTION
2011-10-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HALOPERIDOLDiscontinued
HALOPERIDOL LACTATE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

2011-10-19Labeling · Supplement 8AP
2010-12-03Labeling · Supplement 7AP
2008-04-28Labeling · Supplement 4AP
2007-12-31Labeling · Supplement 3LetterAP
2004-08-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →